Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation

Blood

Volumn 92, Issue 10, 1998, Pages 3605-3615

  Carayon, Pierre ^a   Marchand, Jean ^b   Dussossoy, Danielle ^b   Derocq, Jean Marie ^b   Jbilo, Omar ^b   Bord, Annie ^b   Bouaboula, Monsif ^b   Galiègue, Sylvaine ^b   Mondière, Paul ^b   Pénarier, Géraldine ^b   Le Fur, Gérard ^b   Defrance, Thierry ^b   Casellas, Pierre ^b  

^a SANOFI   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CD40 ANTIGEN; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CHO CELL; CONTROLLED STUDY; GERMINAL CENTER; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032533247     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3605.422k05_3605_3615     Document Type: Article

References (46)

1. Gaoni Y, Mechoulam R: Isolation, structure, and partial synthesis of an active constituent of Hashish. J Am Chem Soc 86:1646, 1964
2. Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC: Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605, 1988
3. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561, 1990
4. Gerard CM, Mollereau C, Vassart G, Parmentier M: Molecular ctoning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129, 1991
5. Howlett AC, Fleming RM: Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532, 1984
6. Mackie K, Hille B: Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825, 1992
7. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P: Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637, 1995
8. Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P: Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270:13973, 1995
9. Gupta S, Grieco MH, Cushman P Jr: Impairment of rosetteforming T lymphocytes in chronic marihuana smokers. N Engl J Med 291:874, 1974
10. Baczynsky WO, Zimmerman AM: Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes. Pharmacology 26:12, 1983
11. Pross S, Klein T, Newton C, Friedman H: Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitro. Int J Immunopharmacol 9:363, 1987
12. Luo YD, Patel MK, Wiederhold MD, Ou DW: Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int J Immunopharmacol 14:49, 1992
13. Klein TW, Kawakami Y, Newton C, Friedman H: Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J Toxicol Environ Health 32:465, 1991
14. Kaminski NE, Koh WS, Yang KH, Lee M, Kessler FK: Suppression of the humoral immune response by cannubinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem Pharmacol 48:1899, 1994
15. Watzl B, Scuderi P, Watson RR: Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro. Int J Immunopharmacol 13:1091, 1991
16. Klein TW, Newton C, Zhu W, Daaka Y, Friedman H: Delta 9-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Proc Soc Exp Biol Med 209:205, 1995
17. McCoy KL, Gainey D, Cabral GA: Delta 9-tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther 273:1216, 1995
18. Kusher DI, Dawson LO, Taylor AC, Djeu JY: Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol 154:99, 1994
19. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376, 1995
20. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61, 1993
21. Lynn AB, Herkenham M: Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268:1612, 1994
22. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240, 1994
23. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P: Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704, 1996
24. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL: Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443, 1995
25. Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P: Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369:177, 1995
26. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P: Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173, 1993
27. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54, 1995
28. Mery L, Boulay F: The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J Biol Chem 269:3457, 1994
29. Oaklander AL, Ekenberg SJ: Small-scale magnetic isolation of mRNA and synthesis of cDNA in 96-well plates. Nature 371:631, 1994
30. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE: Use of the polymerase chain reaction in the quuntitation of mdr-1 gene expression. Biochemistry 29:10351, 1990
31. Aubin JT, Boulay D, Chapus A, Brechot C, Laure F, Agut H: Evaluation of a new non-isotopic sandwich hybridization for the detection of HIV1-specific PCR products. Res Virol 146:75, 1995
32. Hewlett AC, Johnson MR, Melvin LS, Milne GM: Non classical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol Pharmacol 33:297, 1988
33. Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593, 1994
34. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301, 1994
35. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872, 1996
36. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667, 1996
37. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661, 1996
38. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946, 1992
39. Stella N, Schweitzer P, Piomelli D: A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773, 1997
40. Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z: The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling. FEBS Lett 375:143, 1995
41. Slipetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M, Metters KM: Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol 48:352, 1995
42. Lagresle C, Bella C, Defrance T: Phenotypic and functional heterogeneity of the IgD-B cell compartment: Identification of two major tonsillar B cell subsets. Int Immunol 5:1259, 1993
43. Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, Le Fur G, Casellas P: SR144528, an antagonist for the peripheral cannabinoid receptor which behaves as an inverse agonist. J Pharmacol Exp Ther (in press)
44. McMahon SB, Monroe JG: Activation of the p21ras pathway couples antigen receptor stimulation to induction of the primary response gene egr-1 in B lymphocytes. J Exp Med 181:417, 1995
45. Sakata N, Patel HR, Terada N, Aruffo A, Johnson GL, Gelfand EW: Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem 270:30823, 1995
46. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M: Differential activation of ERK and JNK mitogen-activated protein kinase by RAF-1 and MEKK. Science 266:1719, 1994